Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Medulloblastoma].

E Bouffet1, D Frappaz, C Carrie

  • 1Centre Léon-Bérard, Lyon, France.

Pediatrie
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extubation failure: Upper airway obstruction by chewing gum. A case report.

Revista espanola de anestesiologia y reanimacion·2024
Same author

Impact of radiotherapy on survival in resected or unresectable anaplastic thyroid carcinomas, a Rare Cancer Network study.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2022
Same author

Assessment of Karnofsky (KPS) and WHO (WHO-PS) performance scores in brain tumour patients: the role of clinician bias.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2020
Same author

The European Society of Paediatric Oncology Ependymoma-II program Core-Plus model: Development and initial implementation of a cognitive test protocol for an international brain tumour trial.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society·2019
Same author

Molecular screening program to select molecular-based recommended therapies for metastatic cancer patients: analysis from the ProfiLER trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2019
Same author

Klebsiella pneumoniae and Klebsiella oxytoca meningitis in infants. Epidemiological and clinical features.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2018
Same journal

[Colonic atresia: report of a case].

Pediatrie·1993
Same journal

[Psychological aspects of bone marrow donation in donor brothers and sisters in bone marrow transplantation].

Pediatrie·1993
Same journal

[Lethargy in the course of treatment with ranitidine in a newborn infant].

Pediatrie·1993
Same journal

[Delayed detection of hip dislocation: is the physician to blame?].

Pediatrie·1993
Same journal

[Renal tubular acidosis in children].

Pediatrie·1993
Same journal

[CD23: structures, functions and practical perspectives in allergy reactions].

Pediatrie·1993
See all related articles

This review covers recent advances in childhood medulloblastoma, a common brain tumor. It discusses histogenesis, managing side-effects, and improving patient prognosis.

Area of Science:

  • Neuro-oncology
  • Pediatric oncology
  • Cancer research

Context:

  • Medulloblastoma is a primary malignant pediatric brain tumor.
  • Understanding tumor origins and progression is crucial for effective treatment.
  • Managing treatment-related toxicities significantly impacts patient quality of life.

Purpose:

  • To provide a comprehensive overview of recent advancements in medulloblastoma research.
  • To discuss current strategies for managing early and late side-effects of treatment.
  • To review updated prognostic factors and outcomes for pediatric medulloblastoma patients.

Summary:

  • Recent progress in understanding medulloblastoma histogenesis offers insights into tumor biology.
  • Effective management protocols for treatment-related side-effects are evolving.

Related Experiment Videos

  • Updated prognostic information aids in tailoring therapeutic approaches and improving outcomes.

    • Impact:

    • Enhanced understanding of medulloblastoma subtypes and origins.
    • Improved quality of life for pediatric patients through better side-effect management.
    • Optimized treatment strategies leading to better prognosis for childhood brain tumors.